文献速递慢阻肺

COPD患者骨质疏松患病率与危险因素的系统综述与荟萃分析

Prevalence and Risk Factors for Osteoporosis in Individuals With COPD: A Systematic Review and Meta-analysis.
PubMed 文献 · Chest · 2019-07-25

该系统综述与荟萃分析检索EMBASE、CINAHL、MEDLINE和PubMed,纳入58项研究,定量合成COPD患者骨质疏松的患病率与危险因素。汇总全球患病率为38%(95%CI 34-43),COPD使骨质疏松风险增加(OR 2.83),BMI<18.5 kg/m2(OR 4.26)和肌少症(OR 3.65)为显著危险因素。建议对COPD患者筛查骨质疏松及相关危险因素。

要点

  • COPD患者骨质疏松汇总全球患病率为38%(95%CI 34-43)。
  • COPD增加骨质疏松风险(OR 2.83),BMI<18.5 kg/m2(OR 4.26)和肌少症(OR 3.65)为显著危险因素。
  • 建议对COPD患者筛查骨质疏松及相关危险因素。

核心结论

  • 骨质疏松在COPD患者中普遍存在,患病率在许多国家似乎较高且相似。
  • COPD患者应筛查骨质疏松及相关危险因素。

研究设计与样本

  • 系统综述与荟萃分析,检索EMBASE、CINAHL、MEDLINE和PubMed数据库。
  • 由两名评价者独立进行 eligibility 筛选、数据提取和质量评估。
  • 采用荟萃分析确定COPD患者骨质疏松患病率与危险因素,并用荟萃回归探索异质性来源。
  • 共纳入58项研究。

主要发现

  • 58项研究的汇总全球患病率为38%(95%CI 34-43)。
  • COPD的存在增加骨质疏松可能性(OR 2.83)。
  • COPD患者中其他显著危险因素包括BMI<18.5 kg/m2(OR 4.26)和肌少症(OR 3.65)。

临床怎么用

  • 对COPD患者进行骨质疏松筛查,并评估相关危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteoporosis is prevalent in individuals with COPD. Updated evidence is required to complement the previous systematic review on this topic to provide best practice. The aim of this systematic review and meta-analysis was to quantitatively synthesize data from studies with respect to the prevalence and risk factors for osteoporosis among individuals with COPD. METHODS: EMBASE, CINAHL, MEDLINE, and PubMed databases were searched for articles containing the key words "COPD," "osteoporosis," "prevalence," and "risk factor." Eligibility screening, data extraction, and quality assessment of the retrieved articles were conducted independently by two reviewers. Meta-analyses were performed to determine osteoporosis prevalence and risk factors in individuals with COPD. Meta-regression analyses were conducted to explore the sources of heterogeneity. RESULTS: The pooled global prevalence from 58 studies was 38% (95% CI, 34-43). The presence of COPD increased the likelihood of having osteoporosis (OR, 2.83). Other significant risk factors for osteoporosis in COPD patients were BMI < 18.5 kg/m2 (OR, 4.26) and the presence of sarcopenia (OR, 3.65). CONCLUSIONS: Osteoporosis is prevalent in individuals with COPD, and the prevalence seems to be high and similar in many countries. Patients with COPD should be screened for osteoporosis and contributing risk factors.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Chen YW, Ramsook AH, Coxson HO, et al. Prevalence and Risk Factors for Osteoporosis in Individuals With COPD: A Systematic Review and Meta-analysis. Chest. 2019. PMID: 31352034. doi:10.1016/j.chest.2019.06.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。